Programmed Death Ligand-1 (PD-L1) Is an Independent Negative Prognosticator in Western-World Gallbladder Cancer

SIMPLE SUMMARY: Gallbladder cancer (GBC) is an aggressive malignancy with poor prognosis. Currently, therapeutic options are mostly limited to palliative chemotherapy. Considering the advances of immunotherapy, we assessed the expression of the programmed cell death ligand-1 (PD-L1) as the most wide...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancers (Basel)
Auteurs principaux: Albrecht, Thomas, Brinkmann, Fritz, Albrecht, Michael, Lonsdorf, Anke S., Mehrabi, Arianeb, Hoffmann, Katrin, Kulu, Yakup, Charbel, Alphonse, Vogel, Monika N., Rupp, Christian, Köhler, Bruno, Springfeld, Christoph, Schirmacher, Peter, Roessler, Stephanie, Goeppert, Benjamin
Format: Artigo
Langue:Inglês
Publié: MDPI 2021
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8038183/
https://ncbi.nlm.nih.gov/pubmed/33918309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13071682
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires